At the free, LIVE class, you’ll get everything you need to make your decision & upgrade your job in 2025, regardless if you stay or go. Tues Jan 21st 2pET ***Special Prize Giveaway At the free, LIVE class, you’ll get everything you need to make your decision & upgrade your job in 2025, regardless if you stay or go. Tues Jan 21st 2pET REGISTER NOW Get started today before this once in a lifetime opportunity
GloRilla donated $25,000 for a new media center for her alma mater Melrose High.
The pathway that activates AKT3 to drive epithelial-to-mesenchymal transition in pancreatic cancer is revealed.
How fast do you REALLY need to be to play each position in college baseball? In this video, we break down the importance of 60-yard…
Renuka Iyer: A big milestone in Cholangiocarcinoma care / cancer, cholangiocarcinoma, OncoDaily, Oncology, Rachna Shroff, Renuka Iyer
Bio Ascend – Developing your personal brand in GI Oncology / Bio Ascend, cancer, OncoDaily, Oncology
A new analysis, spearheaded by a multi-institutional team of experts, highlights a computational methodology that supports the identification of multiple myeloma patients who are most…
Targeting a cell stress response is synthetic lethal with loss of p53 in prostate cancer cells.
A retrospective study measured real-world outcomes of patients with relapsed or refractory large B-cell lymphoma treated with epcoritamab or glofitamab.
A major report on alcohol’s effects contradicts recent studies in finding that moderate drinkers had lower mortality.
Newly published data suggests most patients are opting for second- or third-generation tyrosine kinase inhibitors instead of a generic form of imatinib.
